Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Meridian
  4. INVAP Nuclear Research Reactor Exports

INVAP Nuclear Research Reactor Exports

Argentina's state-owned INVAP has exported turnkey nuclear research reactors to Australia, Algeria, Egypt, and Saudi Arabia — a rare Southern Hemisphere nuclear technology exporter.

Geography: Americas · South America · Latin America

Back to MeridianBack to Latin AmericaView interactive version

INVAP, a state-owned high-technology company based in Bariloche, Argentina, is one of only a handful of firms worldwide capable of designing and building nuclear research reactors from scratch. Its flagship export is the OPAL reactor built for the Australian Nuclear Science and Technology Organisation (ANSTO) near Sydney — a 20 MW multi-purpose research reactor commissioned in 2007 that produces medical isotopes, conducts neutron science, and irradiates silicon for semiconductor manufacturing. INVAP has also delivered reactors to Algeria (NUR, 1 MW), Egypt (ETRR-2, 22 MW), and is pursuing contracts with Saudi Arabia and other Middle Eastern clients.

What makes INVAP remarkable is its provenance. Argentina developed a complete nuclear fuel cycle and reactor design capability during the 20th century, making it one of the most advanced nuclear-capable nations outside the traditional powers. INVAP emerged from this ecosystem, inheriting deep expertise in reactor physics, fuel element design, and nuclear instrumentation. The company builds not just reactors but also radioisotope production facilities, nuclear medicine centers, and satellite systems — a diversification that has kept it financially viable through Argentina's recurring economic crises. Its reactors typically use low-enriched uranium fuel, making them attractive to countries that want nuclear technology without proliferation concerns.

Strategically, INVAP occupies a unique niche. The global demand for research reactors is growing, driven by the medical isotope market (particularly Molybdenum-99 for diagnostic imaging) and the need for neutron sources in materials science. Many Cold War-era research reactors are approaching end of life, creating a replacement market. INVAP competes against established players like France's Framatome and South Korea's KAERI, but offers a distinctive value proposition: turnkey capability at lower cost, with technology transfer agreements that appeal to developing nations seeking nuclear sovereignty without weapons implications.

TRL
9/9Established
Impact
4/5
Investment
3/5
Category
Applications

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions